Giles AI

What Giles AI does

Giles AI Ltd is a UK-based artificial intelligence company that develops giles®, an AI research agent purpose-built for healthcare, clinical, and life sciences workflows. The platform connects researchers to verified medical databases (PubMed, ClinicalTrials.gov, FDA, NICE) and private document repositories, enabling conversational literature search, document summarization and comparison, side-by-side screening, and structured data extraction (up to 20 columns) with full source traceability and inline cell-level referencing. The LLM-agnostic platform is built on Google Cloud Platform with tailored healthcare-grade AI from Google, supports 40+ languages, and offers configurable verbosity and temperature controls. Compliance posture includes GDPR, Cyber Essentials certification, and SOC2 alignment, with an explicit policy that customer data is not used to train AI models.

The company operates a hybrid go-to-market combining a self-serve product-led growth motion (free tier capped at 500 early access users plus a $199/month Standard plan, currently promoted at $29/month for HLTH Europe 2026) with enterprise field sales targeting pharmaceutical, biotech, and healthcare organizations. Distribution channels include the giles.app web application, a secure enterprise API, direct enterprise sales, and academic/institutional outreach. The company is headquartered in London (124 City Road, EC1V 2NX) with a geographically distributed production team across Bucharest (Romania), Dubai (UAE), and Texas (USA).

Giles AI secured £750,000 in pre-seed funding in June 2025 from angel investors and strategic partner Regulatory Scientific and Health Solutions (R-S-S), with ongoing technology support from Google UK. The company commercially launched giles® in October 2025 at ISPOR Europe 2025 in Glasgow. Reported performance metrics include up to 94% extraction accuracy versus manual methods, 0.98 agreement rate versus subject matter experts, and up to 85% reduction in manual effort in systematic literature review workflows, as validated by an R-S-S case study.

Name

Giles AI

Legal name

Giles AI Ltd

Website

https://giles.app

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Giles AI builds giles®, an AI research agent for healthcare and life sciences that connects to verified medical databases (PubMed, ClinicalTrials.gov, FDA, NICE) to enable conversational literature search, summarization, comparison, and structured data extraction for clinical researchers, pharma/biotech firms, and regulatory professionals.

Ownership category

akta.pro rank

Product category

Healthcare AI Research Software

NAICS

Software Publishers (5132)

SIC

Services-Health Services (8000), Services-Computer Programming Services (7371)

akta.pro primary industry

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

akta.pro secondary industries

DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO), Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)

Keywords

• Healthcare research AI
• Systematic literature review
• Medical data extraction
• Life sciences intelligence
• Evidence synthesis software

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Subscription - Standard Plan: Monthly subscription at $29 per month (reduced from $199 for HLTH Europe 2026 promotion). Full access to all features including AI-agentic access to healthcare databases, unlimited project spaces, customizable data extraction, multi-language support, and document uploads. Billed monthly with 14-day refund policy.
2. Free Tier: Limited free access tier for first 500 users as part of early access offer. Includes 60 queries per month, 3 document uploads per month, limited access to specialized tools, access to source citations, and chat history. Used as product-led growth acquisition channel.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

Core offering

Giles AI builds giles®, a vertical AI research agent for healthcare and life sciences researchers. The platform connects directly to verified medical databases (PubMed, ClinicalTrials.gov, FDA, NICE) and private document repositories to let users chat, search, screen, summarize, compare and extract structured data from academic papers and clinical trial records. It is delivered as a SaaS web application with a Free early-access tier and a $29/month Standard subscription, plus an enterprise API and direct sales motion for pharmaceutical and biotech customers.

Product overview

Giles AI offers a single unified product platform, giles®, built as an AI research agent specialized for healthcare and life sciences. The core product integrates conversational AI for literature review, document comparison, data extraction, and synthesis across multiple interfaces (Chat, Compare, Extract, Summarization, Synopsis). giles® incorporates the Azthena AI scientific assistant for domain-specific research tasks. The platform is delivered as a single Standard subscription tier ($199/month) and connects natively to PubMed and ClinicalTrials.gov for literature and trial search. Use case modules for HTA & Market Access, Evidence Synthesis, PICO Framework, Medical Affairs, Pricing & Reimbursements, and Real World Evidence are available as targeted workflows within the platform. A dedicated AI-driven data extraction module supports systematic literature reviews, and a qualitative Delphi study analysis module serves specific research methodologies.

Differentiator

Problem solved

Functional benefit

Products and services

• giles® AI Research Agent The primary AI research agent for healthcare and life sciences, distributed as a SaaS web application at giles.app and via an enterprise API. It enables researchers to search, summarize, compare, screen and extract data from academic papers, clinical trials and private documents through a conversational interface, connecting natively to PubMed, ClinicalTrials.gov, FDA and NICE databases with multi-language output, structured CSV-exportable data extraction, full source traceability and unlimited project Spaces on the paid plan.

Quantifiable outcome

• 85% reduction in manual effort for systematic literature reviews
• +3 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature9 records

Partnerships

Three partnerships are on record, tiered core and major.

• Regulatory Scientific and Health Solutions (R-S-S)coreStrategic or Co-development Partner · 1 June 2025Strategic partnership for initial development and commercialization of the giles AI platform. R-S-S, a leader in health economics and drug development, supported refinement of the AI agent to connect researchers with open access medical databases. Advisory Board Chair Prof/Dr. Iftekhar Khan from R-S-S helps drive enterprise adoption and validate product direction for regulatory and HEOR use cases.
• Google UKcoreTechnology or IntegrationOngoing support from Google UK for development and enhancement of the giles AI platform. Leverages Google Cloud Platform infrastructure and tailored healthcare-grade AI technology. Partnership enables access to Google's AI capabilities while maintaining LLM-agnostic architecture.
• Pharmaceutical Companies (Collaborations)majorStrategic or Co-development PartnerSeries of high-profile collaborations with pharmaceutical companies, directly connecting researchers to medical databases. Enterprise partnerships for deployment of giles in drug discovery, clinical trials, and regulatory affairs workflows.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Elicit: Elicit is an AI research assistant that searches and summarizes academic papers, including PubMed and clinical trial databases, and is widely used by healthcare and life sciences researchers. It is the most direct competitor to giles® in AI-powered literature review and systematic review workflows.
• Consensus: Consensus is an AI search engine that extracts and synthesizes findings directly from peer-reviewed scientific research, with strong adoption among healthcare and biomedical researchers. It competes head-to-head with giles® for evidence-based answers from the scientific literature.
• Scite: Scite uses AI to classify how scientific papers cite each other and provides evidence-based answers from the literature. Its citation classification and reference analysis features overlap directly with giles®'s citation tracking and source verification capabilities.
• Iris.ai: Iris.ai builds AI tools for scientific research workflow automation, including literature mapping and systematic review support. It targets pharma, R&D, and academic customers with similar use cases to giles® in HTA and evidence synthesis.
• Scholarcy: Scholarcy is an AI summarization tool for academic articles, generating structured summaries and extracting key claims. It directly competes with giles®'s summarization, synopsis, and structured data extraction features.

Emerging players

• Causaly: Causaly is an AI platform for biomedical research that connects evidence across publications, clinical trials, and other data sources to support drug discovery and HEOR. It overlaps with giles® in pharma R&D evidence discovery but with a deeper knowledge graph orientation.
• Litmaps: Litmaps helps researchers discover and visualize connections between academic papers, with strong adoption among academic and clinical researchers. It competes partially with giles®'s document comparison and literature mapping features.
• Connected Papers: Connected Papers builds a graph of papers related to a given field and supports researchers in exploring prior work. It overlaps with giles®'s discovery and screening workflows for literature reviews.
• Research Rabbit: Research Rabbit is a free AI literature mapping tool that helps researchers discover and track related academic papers. It targets a similar end user (individual academic and clinical researchers) and overlaps with giles®'s literature discovery features.

Broad incumbents

• Semantic Scholar (Allen Institute for AI): Semantic Scholar is a widely used AI-augmented academic search engine with extensive coverage of biomedical literature. It serves as a broader incumbent source for literature discovery that giles® integrates alongside rather than replaces, but it competes for researcher attention.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/gileschat
• YouTubem.youtube.com/@gileschat
• LinkedInlinkedin.com/company/gileschat
• Instagraminstagram.com/gileschat
• TikToktiktok.com/@gileschat

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Giles AI